Google+ Facebook Twitter Twitter

Tech news: September 2022

This month's top tech news stories

Agile Life Sciences


A UK start-up is developing an easy-to-use, accurate and reliable diagnostic test that could transform the way the menopause is diagnosed, monitored and managed, it is claimed.

Agile Life Sciences has developed an at-home urine sample collection test that can identify where a woman is during the various stages of her menopausal journey.

It is more accurate and reliable than any current menopause test available, said the start-up.


UltraViolet Dyes

Bio-Rad Laboratories has extended its range of StarBright Dyes to provide greater flexibility in multicolour flow cytometry panels.

The StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 dyes offer improved brightness with narrow excitation and emission profiles for precise resolution.

The range provides researchers with highly stable, validated flow antibodies conjugated to proprietary fluorescent nanoparticles.


Ondine Biomedical

Nasal photodisinfection

Ondine Biomedical has recruited the final patients to its nasal photodisinfection exploratory phase 2 trial. The trial is evaluating how effectively Ondine’s nasal photodisinfection technology eradicates pathogens – specifically Staphylococcus aureus – in the nose.

The single-centre open-label trial has recruited over 300 patients who will undergo a pre-surgery nasal culture to determine the prevalence of Staphylococcus aureus – the main cause of surgical site infections.

Ondine’s nasal photodisinfection is a patented platform.

Image credit | iStock | Ondine-Biomedical | BIO-RAD

Related Articles

My lab: clinical diagnostic parasitology

Unit Manager Jayne Jones gives a guided tour of her laboratory at the Liverpool School of Tropical Medicine.

Point-of-care testing and the new ISO 15189:2022

David Ricketts, Alyson Bryant and Sarah Glover look at accreditation and point-of-care testing.

Automated medical imaging for schistosomiasis diagnosis

Schistosomiasis, a parasitic disease affecting millions worldwide, poses a significant public health and economic burden, particularly in impoverished regions.

Lessons learned from the pandemic

IBMS Chief Executive David Wells was NHS England’s Head of Pathology when COVID struck. He explains what lessons he learned and how they can help the profession. We then hear from a range of IBMS members and scientists on their biggest lessons and takeaways from the pandemic.